Granada, Spain

Germaine Escames Rosa

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovative Contributions of Germaine Escames Rosa

Introduction: Germaine Escames Rosa, an accomplished inventor based in Granada, Spain, has made significant strides in the field of biomedical innovations. With a portfolio that includes four patents, her research primarily focuses on the therapeutic applications of melatonin, demonstrating her commitment to advancing medical science.

Latest Patents: Germaine's latest patents showcase her innovation in drug formulation. One of her notable inventions is a "Durable preparation of an injectable melatonin exhibiting long-term stability." This invention describes an aqueous melatonin composition that maintains long-term stability while allowing high concentrations of this water-insoluble active ingredient, making it particularly useful for intravenous administration. Another significant patent is for the "Use of melatonin for the treatment of tumors," which relates to the preparation of a pharmaceutical composition suitable for intratumoral administration. This composition leverages high concentrations of melatonin, derivatives, or metabolites to exert an oxidizing effect, enhancing free radical production and promoting cell death in tumor cells.

Career Highlights: Germaine has had a distinguished career shaped by her collaborations with prominent institutions. Her work primarily includes associations with the Universidad de Granada and the Servicio Andaluz de Salud, where she has contributed her expertise to enhance healthcare solutions.

Collaborations: Throughout her career, Germaine has worked alongside notable colleagues, including Darío Acuña Castroviejo and Luis Carlos López Garcia. Their collaborative efforts have furthered their shared goals in the pursuit of medical advancements.

Conclusion: Germaine Escames Rosa's innovative research work and her significant contributions to the development of injectable forms of melatonin reflect her dedication to improving therapeutic outcomes. Her inventions not only pave the way for new medical discoveries but also highlight the vital role of inventors like her in the continuous evolution of healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…